Výsledky vyhledávání - "Dov Hershkovizh"

Next generation sequencing in ovarian cancer patients: Does personalized medicine improve oncological outcomes?

Autor: Miriam R. Brezis, T. Safra, Lee Galmor, Yuval Raviv, Shira Peleg Hasson, Lyri Adar, Dov Hershkovizh, Eliya Shachar

Publikováno v: Journal of Clinical Oncology. 39:5553-5553

5553 Background: Ovarian cancer (OC) is the second most common gynecologic malignancy and the most common cause of gynecologic cancer mortality in the United States. Homologous recombination deficiency (HRD), including the BRCA mutations, are found i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::321a4ceec8d7bacb949daa39993cbeb0
https://doi.org/10.1200/jco.2021.39.15_suppl.5553

Zobrazit plný text záznamu

The chick embryo chorioallantoic membrane assay: In ovo model for personalized assessment and evaluation of the most effective therapeutic approach in cancer therapy

Autor: Faina Bedny, Oren Bogin, Ezra Bernstein, Dov Hershkovizh, Ayelet Izhaki, Ido Wolf, Eli Brazowski, Nadir Arber, Shiran Shapira, Dina Kazanov

Publikováno v: Journal of Clinical Oncology. 37:e14634-e14634

e14634 Background: "Personalized medicine,” is the tailoring of medical treatment to a single person aiming to maximize efficacy and minimize toxicity. Currently there is no good prediction for response to therapy. The Chick Chorioallantoic Membran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd003ade506e65bca823dc3b6af64080
https://doi.org/10.1200/jco.2019.37.15_suppl.e14634

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání